Source comparison
Comparison: CJC-1295 with DAC vs. Other GH Secretagogues
Understanding where CJC-1295 with DAC fits into the broader spectrum of GH-releasing peptides is crucial. It's not always about 'better,' but 'appropriate' for the research objective. Here's a quick comparison: CJC-1295 (with DAC) GHRH Analog (binds to albumin
This comparison does not assign a generated winner or score.
- Understanding where CJC-1295 with DAC fits into the broader spectrum of GH-releasing peptides is crucial. It's not always about 'better,' but 'appropriate' for the research objective. Here's a quick comparison:
- CJC-1295 (with DAC)
- GHRH Analog (binds to albumin)
- 6-8 days
- Sustained, pulsatile GH release; reduced dosing frequency; physiological GH patterns. Ideal for long-term studies.
- CJC-1295 (no DAC)
- GHRH Analog
- <30 minutes
- Very short, acute GH pulse; precise, immediate control over GH release. Requires frequent administration.
- Ipamorelin
- GHRP (selective for GH release)
- ~2 hours
- Highly selective GH release; minimal impact on cortisol/prolactin. Often combined with GHRH for synergistic effects.
- GHRP-2
- GHRP (stronger, less selective)
- ~1 hour
- Potent GH release; some appetite stimulation. May cause slight cortisol/prolactin elevation.
- GHRP-6
- GHRP (moderate, significant appetite)
- Moderate GH release; strong appetite stimulation. Useful in models requiring increased caloric intake.
- Sermorelin
- GHRH Analog (shorter fragment)
- 10-20 minutes
- Natural GHRH fragment; short-acting, promotes pulsatile release.
- Tesamorelin
- GHRH Analog (longer fragment)
- ~30 minutes
- Specifically studied for visceral fat reduction in certain populations.
- MK-677
- Oral GH Secretagogue (non-peptide)
- ~24 hours
- Oral bioavailability, stimulates GH release via ghrelin receptor. Sustained action, but not a peptide.
- As you can see, the distinct advantage of CJC-1295 extended half-life GH release is its unparalleled duration of action among the GHRH analogs. While compounds like Ipamorelin or GHRP-6 offer acute, potent bursts, they demand a different research protocol, often involving multiple daily administrations. For researchers seeking sustained physiological support, CJC-1295 (with DAC) is often the compound of choice. We even offer CJC-1295 + Ipamorelin (5mg/5mg) for those who want to explore the synergistic effects of a GHRH and GHRP combination.